Annual Short Term Debt
$1.18 M
+$505.00 K+74.81%
31 December 2023
Summary:
Verona Pharma annual short term debt is currently $1.18 million, with the most recent change of +$505.00 thousand (+74.81%) on 31 December 2023. During the last 3 years, it has risen by +$382.00 thousand (+47.87%). VRNA annual short term debt is now at all-time high.VRNA Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$952.00 K
-$79.00 K-7.66%
30 September 2024
Summary:
Verona Pharma quarterly short term debt is currently $952.00 thousand, with the most recent change of -$79.00 thousand (-7.66%) on 30 September 2024. Over the past year, it has increased by +$576.00 thousand (+153.19%). VRNA quarterly short term debt is now -19.32% below its all-time high of $1.18 million, reached on 31 December 2023.VRNA Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRNA Short Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +74.8% | +153.2% |
3 y3 years | +47.9% | +38.0% |
5 y5 years | +100.0% | +76.0% |
VRNA Short Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +82.1% | -19.3% | +153.2% |
5 y | 5 years | at high | -19.3% | +153.2% | |
alltime | all time | at high | -19.3% |
Verona Pharma Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $952.00 K(-7.7%) |
June 2024 | - | $1.03 M(-7.8%) |
Mar 2024 | - | $1.12 M(-5.3%) |
Dec 2023 | $1.18 M(+74.8%) | $1.18 M(+213.8%) |
Sept 2023 | - | $376.00 K(-31.0%) |
June 2023 | - | $545.00 K(-16.2%) |
Mar 2023 | - | $650.00 K(-3.7%) |
Dec 2022 | $675.00 K(+4.2%) | $675.00 K(+18.6%) |
Sept 2022 | - | $569.00 K(+22.6%) |
June 2022 | - | $464.00 K(-20.4%) |
Mar 2022 | - | $583.00 K(-10.0%) |
Dec 2021 | $648.00 K | $648.00 K(-6.1%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2021 | - | $690.00 K(-7.9%) |
June 2021 | - | $749.00 K(-1.1%) |
Mar 2021 | - | $757.00 K(-5.1%) |
Dec 2020 | $798.00 K(+30.6%) | $798.00 K(-1.2%) |
Sept 2020 | - | $808.00 K(+2.9%) |
June 2020 | - | $785.30 K(+1.9%) |
Mar 2020 | - | $770.60 K(+26.1%) |
Dec 2019 | $611.00 K(>+9900.0%) | $611.00 K(+13.0%) |
Sept 2019 | - | $540.80 K(+161.8%) |
June 2019 | - | $206.60 K(-34.3%) |
Mar 2019 | - | $314.30 K(>+9900.0%) |
Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Verona Pharma annual short term debt?
- What is the all time high annual short term debt for Verona Pharma?
- What is Verona Pharma annual short term debt year-on-year change?
- What is Verona Pharma quarterly short term debt?
- What is the all time high quarterly short term debt for Verona Pharma?
- What is Verona Pharma quarterly short term debt year-on-year change?
What is Verona Pharma annual short term debt?
The current annual short term debt of VRNA is $1.18 M
What is the all time high annual short term debt for Verona Pharma?
Verona Pharma all-time high annual short term debt is $1.18 M
What is Verona Pharma annual short term debt year-on-year change?
Over the past year, VRNA annual short term debt has changed by +$505.00 K (+74.81%)
What is Verona Pharma quarterly short term debt?
The current quarterly short term debt of VRNA is $952.00 K
What is the all time high quarterly short term debt for Verona Pharma?
Verona Pharma all-time high quarterly short term debt is $1.18 M
What is Verona Pharma quarterly short term debt year-on-year change?
Over the past year, VRNA quarterly short term debt has changed by +$576.00 K (+153.19%)